My Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-06-2024
- Paid Up Capital ₹ 1.50 M
as on 16-06-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.08 Cr
as on 16-06-2024
- Revenue 73.82%
(FY 2023)
- Profit 565.60%
(FY 2023)
- Ebitda 57.02%
(FY 2023)
- Net Worth 6.12%
(FY 2023)
- Total Assets 6.90%
(FY 2023)
About My Biotech
The Corporate was formerly known as Mb Corporation Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.08 Cr.
Yatindra Singh and Sangeeta Singh serve as directors at the Company.
- CIN/LLPIN
U52602MH2012PTC226649
- Company No.
226649
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2012
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does My Biotech Private Limited offer?
My Biotech Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Autoclaves, Sterilizers & Incubators, Lab Incubator, Laboratory Chamber, Anaerobic Chamber, Spectrophotometer, Incubator Shaker, Laboratory Centrifuge, Centrifuge Machine.
Who are the key members and board of directors at My Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yatindra Singh  | Director | 10-Feb-2012 | Current |
| Sangeeta Singh | Director | 10-Feb-2012 | Current |
Financial Performance and Corporate Structure Insights of My Biotech.
My Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 73.82% increase. The company also saw a substantial improvement in profitability, with a 565.6% increase in profit. The company's net worth moved up by a moderate rise of 6.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of My Biotech?
In 2023, My Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ysa Biotec Private LimitedActive 9 years 6 monthsYatindra Singh and Sangeeta Singh are mutual person
- Vantageceo Advisory Private LimitedActive 5 years 3 months
Yatindra Singh and Sangeeta Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2016 | ₹3.79 M | Open |
Others Creation Date: 30 Mar 2013 | ₹7.00 M | Open |
How Many Employees Work at My Biotech?
Unlock and access historical data on people associated with My Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of My Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped My Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
